Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BUB1 | O43683 | 20/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17372040 | 0.91 | BUB1 (1.00) | BUB1 | |
| SCHEMBL18481851 | 0.89 | BUB1 (0.77) | BUB1 | |
| SCHEMBL20233916 | 0.89 | BUB1 (1.00) | BUB1 | |
| SCHEMBL18319970 | 0.89 | BUB1 (1.00) | BUB1 | |
| SCHEMBL18438873 | 0.88 | BUB1 (0.82) | BUB1 | |
| SCHEMBL20470379 | 0.88 | BUB1 (0.84) | BUB1 | |
| SCHEMBL17372047 | 0.88 | BUB1 (1.00) | BUB1 | |
| SCHEMBL18438989 | 0.86 | BUB1 (0.72) | BUB1 | |
| SCHEMBL18481378 | 0.86 | BUB1 (1.00) | BUB1 | |
| SCHEMBL18320142 | 0.86 | BUB1 (1.00) | BUB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3331611-B1 | 1H-PYRROL-3-AMINES | Bayer Pharma AG (DE) | 2021-06-02 | — | — | EP | disclosed |
| EP-3331611-B1 | 1H-PYRROL-3-AMINES | Bayer Pharma AG (DE) | 2021-06-02 | — | — | EP | disclosed |
| EP-3310775-B1 | 3-AMINO-1,5,6,7-TETRAHYDRO-4H-INDOL-4-ONES | Bayer Pharma AG (DE) | 2020-04-01 | — | — | EP | disclosed |
| EP-3310775-B1 | 3-AMINO-1,5,6,7-TETRAHYDRO-4H-INDOL-4-ONES | Bayer Pharma AG (DE) | 2020-04-01 | — | — | EP | disclosed |
| US-10308629-B2 | 1H-pyrrol-3-amines | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-06-04 | — | — | US | disclosed |
| US-20180222881-A1 | 1H-PYRROL-3-AMINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-08-09 | — | — | US | disclosed |
| EP-3331611-A1 | 1H-PYRROL-3-AMINES | Bayer Pharma Aktiengesellschaft (DE) | 2018-06-13 | — | — | EP | disclosed |
| WO-2017021348-A1 | 1H-PYRROL-3-AMINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222881-A1 | 1H-PYRROL-3-AMINES | PAH, ADCYAP1R1, NPPA | BUB1 1697/4885 |
| US-10308629-B2 | 1H-pyrrol-3-amines | PAH, ADCYAP1R1, NPPA | BUB1 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.